SlideShare une entreprise Scribd logo
1  sur  42
LOK RAJ BHANDARI
LIVER FUNCTION TEST
(LFT)
5/23/2017 1
LIVER
 The liver is the largest organ in the
body.
 It is located below the diaphragm in
the right upper quadrant of the
abdominal cavity and extended
approximately from the right 5th rib
to the lower border of the rib cage.
• The liver performs an astonishingly
large number of tasks that impact all
body systems.
5/23/2017 2
Functions of liver
① Excretory function: bile pigments, bile salts and
cholesterol are excreted in bile into intestine.
② Metabolic function: liver actively participates in
carbohydrate, lipid, protein, mineral and vitamin
metabolisms.
③ Hematological function: liver is also produces
clotting factors like factor V, VII. Fibrinogen
involved in blood coagulation is also synthesized
in liver. It synthesize plasma proteins and
destruction of erythrocytes.
5/23/2017 3
Storage functions: glycogen, vitamins A, D and B12,and
trace element iron are stored in liver.
Protective functions and detoxification: Ammonia is
detoxified to urea. kupffer cells of liver perform
phagocytosis to eliminate foreign compounds. Liver is
responsible for the metabolism of xenobiotic.
5/23/2017 4
LIVER FUNCTIO N TEST
• Liver function tests(LFT) are helpful to detect the
abnormalities and extent of liver damage.
• LFT assays are frequently more sensitive than clinical signs
and symptoms.
• Typically the LFT comprises of:
- Total protein
– Albumin and globulin
– (Prothrombin Time)
– Transaminases – AST & ALT
– Alkaline PO4ase
– Bilirubin, usually fractionated
– Gamma Glutamyl Transpeptidase (GGT)5/23/2017 5
Purpose of LFTs
• LFTs alone do not give the physician full information, but
used in combination with a careful history, physical
examination (particularly ultrasound and CT Scanning), can
contribute to making an accurate diagnosis of the specific
liver disorder.
• Different tests will show abnormalities in response to
 liver inflammation
 liver injury due to drugs, alcohol, toxins, viruses
 Liver malfunction due to blockage of the flow of bile
 Liver cancers
5/23/2017 6
Classification of liver functions test
Classified based on the major functions of liver:
① Excretion: Measurement of bile pigments, bile salts.
② Serum enzymes: Transaminase (ALT, AST), alkaline
phosphate(ALP), 5’-nucleotidase, LDH isoenzyme.
③ Synthetic function: Prothrombin time, serum albumin.
④ Metabolic capacity: Galactose tolerance and antipyrine
clearance
⑤ Detoxification :
5/23/2017 7
Serum Bilirubin
• Bilirubin is the
catabolic product of
haemoglobin produced
within the
reticuloendothelial
system, released in
unconjugated form
which enters into the
liver, converted to
conjugated forms
bilirubin mono and
diglucuronides by the
enzyme UDP-
glucuronyltransferase.5/23/2017 8
Normal serum bilirubin levels:
• Total bilirubin: 4 to 19mol/L
• Conjugated bilirubin (Direct ; glucuronide): 0 to 4 mol/L
• Unconjugated bilirubin ( Indirect; bilirubin - albumin
complex): up to 12 mol/L
• The serum bilirubin levels more than 17μmol/L suggest
liver diseases and levels above 24μmol/L indicate abnormal
laboratory liver tests . Jaundice occurs when bilirubin
becomes visible within the sclera, skin, and mucous
membranes at a blood concentration of around 40 µmol/L .
5/23/2017 9
• The occurrence of unconjugated hyperbilirubinemia due to
over production of bilirubin, decreased hepatic uptake or
conjugation or both. It is observed in genetic defect of
UDP-glucuronyltransferase causing Gilbert's syndrome,
Crigler-Najjar syndrome and reabsorption of large
hematomas and ineffective erythropoiesis.
• In viral hepatitis, hepatocellular damage, toxic or ischemic
liver injury higher levels of serum conjugated bilirubin is
seen. Hyperbilirubinemia in acute viral hepatitis is directly
proportional to the degree of histological injury of
hepatocytes and the longer course of the disease .
5/23/2017 10
• It has been observed that the decrease of conjugated
serum bilirubin is a bimodal fashion when the biliary
obstruction is resolved.
• Parenchymal liver diseases or incomplete extrahepatic
obstruction due to biliary canaliculi give lower serum
bilirubin value than those occur with malignant obstruction
of common bile duct but the level remains normal in
infiltrative diseases like tumours and granuloma.
• Raised Serum bilirubin from 20.52 µmol/L to 143.64µmol/L
in acute inflammation of appendix has been observed.
5/23/2017 11
• In normal asymptomatic pregnant women total and free
bilirubin concentrations were significantly lower during all
three trimesters and a decreased conjugated bilirubin was
observed in the second and third trimesters. The recent
study has shown that a high serum total bilirubin level may
protect neurologic damage due to stroke.
5/23/2017 12
Alanine amino transferase (ALT)
• ALT is found in kidney, heart, muscle and greater
concentration in liver compared with other tissues of the
body. ALT is purely cytoplasmic catalysing the
transamination reaction.
• Normal serum ALT is 7-56 U/ L
• Any type of liver cell injury can reasonably increases ALT
levels.
• Elevated values up to 300 U/L are considered nonspecific.
Marked elevations of ALT levels greater than 500 U/L
observed most often in persons with diseases that affect
primarily hepatocytes such as viral hepatitis, ischemic liver
injury (shock liver) and toxin-induced liver damage.
5/23/2017 13
• Despite the association between greatly elevated ALT
levels and its specificity to hepatocellular diseases, the
absolute peak of the ALT elevation does not correlate with
the extent of liver cell damage .
• Viral hepatitis like A, B, C, D and E may be responsible for a
marked increase in aminotransferase levels. The increase in
ALT associated with hepatitis C infection tends to be more
than that associated with hepatitis A or B .
• Moreover in patients with acute hepatitis C serum ALT is
measured periodically for about 1 to 2 years. Persistence of
elevated ALT for more than six months after an occurrence
of acute hepatitis is used in the diagnosis of chronic
hepatitis.
5/23/2017 14
• Elevation in ALT levels are greater in persons with
nonalcoholic steatohepatitis than in those with
uncomplicated hepatic steatosis . In a recent study the
hepatic fat accumulation in childhood obesity and
nonalcoholic fatty liver disease causes serum ALT elevation.
• Moreover increased ALT level was associated with reduced
insulin sensitivity, adiponectin and glucose tolerance as
well as increased free fatty acids and triglycerides. Presence
of Bright liver and elevated plasma ALT level was
independently associated with increased risk of the
metabolic syndrome in adults. ALT level is normally
elevated during 2nd trimester in asymptomatic normal
pregnancy.
5/23/2017 15
• In one of the study, serum ALT levels in symptomatic
pregnant patients such as in hyperemesis gravidarum was
103.5U/L, in pre-eclampsia patients was 115U/L and in
haemolysis with low platelet count patients showed
149U/L. However in the same study ALT rapidly drops more
than 50% of the elevated values within 3 days indicating
the improvement during postpartum.
• One of the recent study has shown that coffee and caffeine
consumption reduces the risk of elevated serum ALT
activity in excessive alcohol consumption, viral hepatitis,
iron overload, overweight, and impaired glucose
metabolism.
5/23/2017 16
Aspartate amino transferase (AST)
• AST catalyse transamination reaction. AST exist two different
isoenzyme forms which are genetically distinct, the
mitochondrial and cytoplasmic form.
• AST is found in highest concentration in heart compared with
other tissues of the body such as liver, skeletal muscle and
kidney.
• Normal serum AST is 0 to 35U/L .
• Elevated mitochondrial AST seen in extensive tissue necrosis
during myocardial infarction and also in chronic liver diseases
like liver tissue degeneration and necrosis .
• About 80% of AST activity of the liver is contributed by the
mitochondrial isoenzyme, whereas most of the circulating AST
activity in normal people is derived from the cytosolic
isoenzyme .
5/23/2017 17
• However the ratio of mitochondrial AST to total AST activity
has diagnostic importance in identifying the liver cell
necrotic type condition and alcoholic hepatitis .
• AST elevations often predominate in patients with cirrhosis
and even in liver diseases that typically have an increased
ALT .
• AST levels in symptomatic pregnant patient in hyperemesis
gravidarum were 73U/L, in pre-eclampsia 66U/L, and 81U/L
was observed in hemolysis with low platelet count and
elevated liver enzymes.
5/23/2017 18
AST/ALT ratio
• The ratio of AST to ALT has more clinical utility than
assessing individual elevated levels. A coenzyme pyridoxal-
5'-phosphate deficiency may depress serum ALT activity
and consequently increases the AST/ALT ratio
• . The ratio increases in progressive liver functional
impairment and found 81.3% sensitivity and 55.3%
specificity in identifying cirrhotic patients .
• Whereas mean ratio of 1.45 and 1.3 was found in alcoholic
liver disease and post necrotic cirrhosis respectively. The
ratio greater than 1.17 was found in one year survival
among patients with cirrhosis of viral cause with 87%
sensitivity and 52% specificity .
5/23/2017 19
• An elevated ratio greater than 1 shows advanced liver
fibrosis and chronic hepatitis C infection. However, an
AST/ALT ratio greater than 2 characteristically is present in
alcoholic hepatitis.
• A recent study differentiated nonalcoholic steatohepatitis
(NASH) from alcoholic liver disease showing AST/ALT ratio
of 0.9 in NASH and 2.6 in patients with alcoholic liver
disease. A mean ratio of 1.4 was found in patients with
cirrhosis related to NASH. Wilson's disease can cause the
ratio to exceed 4.5 and similar such altered ratio is found
even in Hyperthyroidism.
5/23/2017 20
Alkaline phosphatase (ALP)
• ALP is present in mucosal epithelia of small intestine, proximal
convoluted tubule of kidney, bone, liver and placenta.
• It performs lipid transportation in the intestine and calcification
in bone. The serum ALP activity is mainly from the liver with
50% contributed by bone .
• Normal serum ALP is 41 to 133U/L .
• In acute viral hepatitis, ALP usually remains normal or
moderately increased.
• Elevation of ALP with prolonged itching is related with Hepatitis
A presenting cholestasis. Tumours secrete ALP into plasma and
there are tumour specific isoenzymes such as Regan, Nagao and
Kasahara . Hepatic and bony metastasis can also cause elevated
levels of ALP.5/23/2017 21
• Other diseases like infiltrative liver diseases, abscesses,
granulomatous liver disease and amyloidosis may cause a
rise in ALP. Mildly elevated levels of ALP may be seen in
cirrhosis, hepatitis and congestive cardiac failure.
• Low levels of ALP occur in hypothyroidism, pernicious
anaemia, zinc deficiency and congenital hypophosphatasia.
• ALP activity was significantly higher in the third trimester
of asymptomatic normal pregnancy showing extra
production from placental tissue.
• ALP levels in hyperemesis gravidarum were 21.5U/L, in
pre-eclampsia 14U/L, and 15U/L in haemolysis with low
platelet count was seen during symptomatic pregnancy.5/23/2017 22
• Transient hyperphosphataemia in infancy is a benign
condition characterized by elevated ALP levels of several
folds without evidence of liver or bone disease and it
returns to normal level by 4 months.
• ALP has been found elevated in peripheral arterial disease,
independent of other traditional cardiovascular risk factors.
Often clinicians are more confused in differentiating liver
diseases and bony disorders when they see elevated ALP
levels and in such situations measurement of gamma
glutamyl transferase assists as it is raised only in cholestatic
disorders and not in bone diseases.
5/23/2017 23
Gamma Glutamyl Transferase (GGT)
• GGT is a microsomal enzyme present in hepatocytes and
biliary epithelial cells, renal tubules, pancreas and intestine.
• It is also present in cell membrane performing transport of
peptides into the cell across the cell membrane and
involved in glutathione metabolism.
• Serum GGT activity mainly attributed to hepatobiliary
system even though it is found in more concentration in
renal tissue .
• The normal level of GGT is 9 to 85 U/L .
• In acute viral hepatitis the levels of GGT will reach the peak
in the second or third week of illness and in some patients
remain elevated for 6 weeks .5/23/2017 24
• Increased level is seen in about 30% of patients with chronic
hepatitis C infection . Other conditions like uncomplicated
diabetes mellitus, acute pancreatitis, myocardial infarction,
anorexia nervosa, Gullian barre syndrome, hyperthyroidism,
obesity and dystrophica myotonica caused elevated levels of
GGT .
• Elevated serum GGT levels of more than 10 times is observed in
alcoholism. It is partly related to structural liver damage,
hepatic microsomal enzyme induction or alcoholic pancreatic
damage .
• GGT can also be an early marker of oxidative stress since serum
antioxidant carotenoids namely lycopene, α-carotene, β-
carotene, and β-cryptoxanthin are inversely associated with
alcohol-induced increase of serum GGT found in moderate and
heavy drinkers .5/23/2017 25
• GGT levels may be 2–3 times greater than the upper
reference value in more than 50% of the patients with
nonalcoholic fatty liver disease.
• There is a significant positive correlation between serum
GGT and triglyceride levels in diabetes and the level
decreases with treatment especially when treated with
insulin.
• Whereas serum GGT does not correlate with hepatomegaly
in diabetes mellitus. Serum GGT activity was significantly
lower in the second and third trimesters of normal
asymptomatic pregnancy.
5/23/2017 26
• The levels of GGT in hyperemesis gravidarum was 45U/L, in
pre- eclampsia 17U/L, and 35U/L in hemolysis with low
platelet count and elevated liver enzymes was found during
symptomatic pregnancy [4]. The primary usefulness of GGT
is limited in ruling out bone disease as GGT is not found in
bone.
5/23/2017 27
5’ Nucleotidase (NTP)
• NTP is a glycoprotein generally disseminated throughout the
tissues of the body localised in cytoplasmic membrane
catalyzing release of inorganic phosphate from nucleoside-5-
phosphates.
• The normal range established is 0 to 15U/L .
• Raised levels of NTP activity were found in patients with
obstructive jaundice, parenchymal liver disease, hepatic
metastases and bone disease .
• NTP is precise marker of early hepatic primary or secondary
tumours. ALP levels also increased in conjugation with NTP
showing intra or extra hepatic obstruction due to malignancy.
• Elevation of NTP is found in acute infective hepatitis and also in
chronic hepatitis.5/23/2017 28
• In acute hepatitis elevation of NTP activity is more when
compared with chronic hepatitis and it is attributed to
shedding of plasma membrane with ecto NTP activity due
to cell damage, or leakage of bile containing high NTP
activity . Serum NTP activity was slightly but significantly
higher in the second and third trimesters of pregnancy .
5/23/2017 29
Ceruloplasmin
• Ceruloplasmin is synthesized in the liver and is an acute phase
protein. It binds with the copper and serves as a major carrier for
copper in the blood .
• Normal plasma level of ceruloplasmin is 200 to 600mg/L .
• The level is elevated in infections, rheumatoid arthritis, pregnancy,
non Wilson liver disease and obstructive jaundice. Low levels may
also be seen in neonates, menke’s disease, kwashiorkor, marasmus,
protein losing enteropathy, copper deficiency and
aceruloplasminemia .
• In Wilson's disease ceruloplasmin level is depressed. Decreased rate
of synthesis of the ceruloplasmin is responsible for copper
accumulation in liver because of copper transport defect in golgi
apparatus, since ATP7B is affected .
• Serum ceruloplasmin levels were elevated in the chronic active liver
disease (CALD) but lowered in the Wilson’s disease (WD). Hence it is
the most reliable routine chemical screening test to differentiate
between CALD and WD.
5/23/2017 30
α-fetoprotein (AFP)
• AFP is the major serum protein in the developing
mammalian foetus produced at high levels by the foetal
liver and visceral endoderm of the yolk sac and at low
levels by foetal gut and kidney.
• AFP is required for female fertility during embryonic
development by protecting the developing female brain
from prenatal exposure to estrogen . In response to liver
injury and during the early stages of chemical
hepatocarcinogenesis led to the conclusion that maturation
arrest of liver-determined tissue stem cells give rise to
hepatocellular carcinomas.
5/23/2017 31
• The normal level of AFP is 0 to 15µg/L
• . An AFP value above 400 - 500µg/L has been considered to
be diagnostic for hepatocellular carcinoma (HCC) in
patients with cirrhosis.
• A high AFP concentration ≥ 400µg/L in HCC patients is
associated with greater tumour size, bilobar involvement,
portal vein invasion and a lower median survival rate .
• Higher serum AFP levels independently predict a lower
sustained virological response (SVR) rate among patients
with chronic hepatitis C .
5/23/2017 32
• There are three different AFP variants, differing in their
sugar chains (AFP-L1, AFP-L2, AFP-L3). AFP-L agglutinin
(LCA) -bound fraction, is the main glycoform of AFP in the
serum of patients with non- malignant chronic liver
disease. In contrast, Lens culinaris-reactive AFP, also known
as AFP-L3, is the main glycoform of AFP in the serum of
HCC patients and it can be detected in approximately one
third of patients with small HCC (< 3 cm), when cut-off
values of 10% to 15% are used. AFP-L3 acts as a marker for
clearance of HCC after treatment. It is reported that an
AFP-L3 level of 15% or more is correlated with HCC-
associated portal vein invasion.
5/23/2017 33
• Estimating the AFP-L3 / AFP ratio is helpful in diagnosis and
prognosis of HCC.
• There is a direct association between second- trimester
maternal serum alpha-fetoprotein levels and the risk of
sudden infant death syndrome (SIDS), which may be
mediated in part through impaired foetal growth and
preterm birth.
5/23/2017 34
Prothrombin time and INR
• The prothrombin time (also called the “protime” or PT) and
the INR are tests used to assess blood clotting. Blood
clotting factors are proteins made by the liver. When the
liver is significantly injured, these proteins are not
produced normally. The PT and INR are also useful liver
function tests since there is a good correlation between
abnormalities in coagulation measured by these tests and
the degree of liver dysfunction. The values for the PT are
usually expressed in seconds and compared to a control
patient’s blood (normal +/- 2 seconds of control).
5/23/2017 35
Albumin
• Albumin is a major protein which is formed by the liver.
Although there are many factors which can affect the level
of albumin circulating in the blood, chronic liver disease
causes a decrease in the amount of albumin produced, and
therefore the level of albumin in the blood is reduced.
Albumin is also part of most automated chemistry
screening panels (normal > 35 g/L).
5/23/2017 36
Other Liver Tests
• Highly specialized tests may be used to indicate more
specifically the presence of certain liver diseases. For
example:Specific antibodies, proteins, and nucleic acids
may be used to indicate the presence of viral hepatitis B
(HBsAg, HBV DNA) or C (eg. anti-HCV antibodies, HCV RNA).
• Elevations in the serum iron, transferrin saturation and
ferritin may indicate the presence of hemochromatosis.
• A deficiency of ceruloplasmin is usually seen in patients
with a copper metabolism disorder called Wilson disease.
5/23/2017 37
• A low level of alpha-1-antitrypsin may indicate the
presence of lung and/or liver disease in children and
adults due to alpha-1-antitrypsin deficiency.
• Immunologic tests such as the antimitochondrial
antibody may suggest the presence of primary biliary
cholangitis (PBC). Antinuclear and/or anti-smooth muscle
antibodies may indicate the presence of autoimmune
hepatitis.
5/23/2017 38
5/23/2017 39
Conclusion
• Laboratory liver tests help to elucidate the alteration of markers
which reflect the liver disease. The assessment of enzyme
abnormalities like, the predominant pattern of enzyme
alteration, the magnitude of enzyme alteration in the case of
aminotransferases, isolated elevation or in conjugation with
some other parameter, the rate of change and the nature of the
course of alteration or follow up of 6 months to 1-2 years helps
in the diagnosis of the disease.
• But a single laboratory liver test is of little value in screening for
liver disease as many serious liver diseases may be associated
with normal levels and abnormal levels might be found in
asymptomatic healthy individuals. The pattern of enzyme
abnormality, interpreted in the context of the patient’s
symptoms can aid in directing the subsequent diagnosis.5/23/2017 40
REFERENCES
1.Thapa BR, Anuj W. Liver Function Tests and their
Interpretation. Indian J Pediatr 2007; 74: 663- 671.
2.Wong HY, Tan JYL, Lim CC. Abnormal liver function test in
symptomatic pregnant patient: The local experience in
Singapore. Annals academy of Medicine 2004; 33: 204-208.
3. Beckingham IJ, Ryder SD. Clinical review ABC of diseases of
liver, pancreas, and biliary system Investigation of liver and
biliary disease. BMJ 2001; 322: 33-36.
4. AGA Technical Review on the Evaluation of Liver Chemistry
Tests. Gastroenterology 2002; 123: 1367–1384.
5/23/2017 41
5.Sayal SK, Gupta CM, Das AL, et al. A comparative study of
liver function tests in patients of chronic liver disorders
with and without cutaneous manifestations. Ind J Dermatol
Venereol Leprol 1997; 63: 15-19.
5/23/2017 42

Contenu connexe

Tendances (20)

Liver function tests and their clinical applications
Liver function tests and their clinical applicationsLiver function tests and their clinical applications
Liver function tests and their clinical applications
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver Function Tests
Liver Function TestsLiver Function Tests
Liver Function Tests
 
LIVER FUNCTION TEST
LIVER FUNCTION TESTLIVER FUNCTION TEST
LIVER FUNCTION TEST
 
Liver Function Tests
Liver Function TestsLiver Function Tests
Liver Function Tests
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
liver function test
liver function testliver function test
liver function test
 
Renal function test
Renal function testRenal function test
Renal function test
 
Kft
KftKft
Kft
 
Serum bilirubin (ANALYTICAL )
Serum bilirubin (ANALYTICAL )Serum bilirubin (ANALYTICAL )
Serum bilirubin (ANALYTICAL )
 
Liver function tests 2020
Liver function tests 2020Liver function tests 2020
Liver function tests 2020
 
Evaluation of liver function tests ppt
Evaluation of liver function tests pptEvaluation of liver function tests ppt
Evaluation of liver function tests ppt
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function test (LFT)
Liver function test (LFT)Liver function test (LFT)
Liver function test (LFT)
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Renal function test
Renal function testRenal function test
Renal function test
 
GASTRIC FUNCTION TESTS
GASTRIC FUNCTION TESTS GASTRIC FUNCTION TESTS
GASTRIC FUNCTION TESTS
 
Billirubin estimation
Billirubin estimationBillirubin estimation
Billirubin estimation
 
Liver Function Test
Liver Function TestLiver Function Test
Liver Function Test
 
Renal function test
Renal function testRenal function test
Renal function test
 

Similaire à Liver Function test

Kenyatta university. liver funtion test
Kenyatta university. liver funtion testKenyatta university. liver funtion test
Kenyatta university. liver funtion testLando Elvis
 
Evaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemiasEvaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemiasDeepujjwal
 
Liver function tests
Liver function testsLiver function tests
Liver function testsRishabh Gupta
 
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptxANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptxrijjorajoo
 
Biochemical functions of Liver.pptx
Biochemical functions of Liver.pptxBiochemical functions of Liver.pptx
Biochemical functions of Liver.pptxHamidhussain73
 
Approach to evaluation of liver disorders
Approach to evaluation of liver disordersApproach to evaluation of liver disorders
Approach to evaluation of liver disordersArabinda Bhattarai
 
liver enzymes markers.pptx
liver enzymes markers.pptxliver enzymes markers.pptx
liver enzymes markers.pptxEsterDad
 
6. The Liver Notes
6. The Liver Notes6. The Liver Notes
6. The Liver NotesLeah Molai
 

Similaire à Liver Function test (20)

Kenyatta university. liver funtion test
Kenyatta university. liver funtion testKenyatta university. liver funtion test
Kenyatta university. liver funtion test
 
The liver
The liverThe liver
The liver
 
Evaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemiasEvaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemias
 
201103coates.pdf
201103coates.pdf201103coates.pdf
201103coates.pdf
 
201103coates
201103coates201103coates
201103coates
 
Investigating a case of alcoholic liver disease
Investigating a case of alcoholic liver diseaseInvestigating a case of alcoholic liver disease
Investigating a case of alcoholic liver disease
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptxANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
 
Liver Functions tests
Liver Functions testsLiver Functions tests
Liver Functions tests
 
Biochemical functions of Liver.pptx
Biochemical functions of Liver.pptxBiochemical functions of Liver.pptx
Biochemical functions of Liver.pptx
 
Liver diseases
Liver diseasesLiver diseases
Liver diseases
 
Approach to evaluation of liver disorders
Approach to evaluation of liver disordersApproach to evaluation of liver disorders
Approach to evaluation of liver disorders
 
LFT L - 4.pptx
LFT L - 4.pptxLFT L - 4.pptx
LFT L - 4.pptx
 
Case Study
Case StudyCase Study
Case Study
 
liver enzymes markers.pptx
liver enzymes markers.pptxliver enzymes markers.pptx
liver enzymes markers.pptx
 
SILD 2021.pdf
SILD 2021.pdfSILD 2021.pdf
SILD 2021.pdf
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
6. The Liver Notes
6. The Liver Notes6. The Liver Notes
6. The Liver Notes
 
Abnormal liver function tests
Abnormal liver function testsAbnormal liver function tests
Abnormal liver function tests
 

Plus de Lok Raj Bhandari

Health promotion: As a pharmacist
Health promotion: As a pharmacistHealth promotion: As a pharmacist
Health promotion: As a pharmacistLok Raj Bhandari
 
Sore throat, diagnosis and management for Pharmacist
Sore throat, diagnosis and management for PharmacistSore throat, diagnosis and management for Pharmacist
Sore throat, diagnosis and management for PharmacistLok Raj Bhandari
 
Cold and flu, its diagnosis and treatment for Pharmacist
Cold and flu, its diagnosis and treatment for PharmacistCold and flu, its diagnosis and treatment for Pharmacist
Cold and flu, its diagnosis and treatment for PharmacistLok Raj Bhandari
 
Cough, diagnosis and its treatment
Cough, diagnosis  and its treatmentCough, diagnosis  and its treatment
Cough, diagnosis and its treatmentLok Raj Bhandari
 
Absorption and distribution of drugs
Absorption and distribution of drugsAbsorption and distribution of drugs
Absorption and distribution of drugsLok Raj Bhandari
 

Plus de Lok Raj Bhandari (6)

Health promotion: As a pharmacist
Health promotion: As a pharmacistHealth promotion: As a pharmacist
Health promotion: As a pharmacist
 
Sore throat, diagnosis and management for Pharmacist
Sore throat, diagnosis and management for PharmacistSore throat, diagnosis and management for Pharmacist
Sore throat, diagnosis and management for Pharmacist
 
Cold and flu, its diagnosis and treatment for Pharmacist
Cold and flu, its diagnosis and treatment for PharmacistCold and flu, its diagnosis and treatment for Pharmacist
Cold and flu, its diagnosis and treatment for Pharmacist
 
Cough, diagnosis and its treatment
Cough, diagnosis  and its treatmentCough, diagnosis  and its treatment
Cough, diagnosis and its treatment
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
 
Absorption and distribution of drugs
Absorption and distribution of drugsAbsorption and distribution of drugs
Absorption and distribution of drugs
 

Dernier

Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 

Dernier (20)

Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 

Liver Function test

  • 1. LOK RAJ BHANDARI LIVER FUNCTION TEST (LFT) 5/23/2017 1
  • 2. LIVER  The liver is the largest organ in the body.  It is located below the diaphragm in the right upper quadrant of the abdominal cavity and extended approximately from the right 5th rib to the lower border of the rib cage. • The liver performs an astonishingly large number of tasks that impact all body systems. 5/23/2017 2
  • 3. Functions of liver ① Excretory function: bile pigments, bile salts and cholesterol are excreted in bile into intestine. ② Metabolic function: liver actively participates in carbohydrate, lipid, protein, mineral and vitamin metabolisms. ③ Hematological function: liver is also produces clotting factors like factor V, VII. Fibrinogen involved in blood coagulation is also synthesized in liver. It synthesize plasma proteins and destruction of erythrocytes. 5/23/2017 3
  • 4. Storage functions: glycogen, vitamins A, D and B12,and trace element iron are stored in liver. Protective functions and detoxification: Ammonia is detoxified to urea. kupffer cells of liver perform phagocytosis to eliminate foreign compounds. Liver is responsible for the metabolism of xenobiotic. 5/23/2017 4
  • 5. LIVER FUNCTIO N TEST • Liver function tests(LFT) are helpful to detect the abnormalities and extent of liver damage. • LFT assays are frequently more sensitive than clinical signs and symptoms. • Typically the LFT comprises of: - Total protein – Albumin and globulin – (Prothrombin Time) – Transaminases – AST & ALT – Alkaline PO4ase – Bilirubin, usually fractionated – Gamma Glutamyl Transpeptidase (GGT)5/23/2017 5
  • 6. Purpose of LFTs • LFTs alone do not give the physician full information, but used in combination with a careful history, physical examination (particularly ultrasound and CT Scanning), can contribute to making an accurate diagnosis of the specific liver disorder. • Different tests will show abnormalities in response to  liver inflammation  liver injury due to drugs, alcohol, toxins, viruses  Liver malfunction due to blockage of the flow of bile  Liver cancers 5/23/2017 6
  • 7. Classification of liver functions test Classified based on the major functions of liver: ① Excretion: Measurement of bile pigments, bile salts. ② Serum enzymes: Transaminase (ALT, AST), alkaline phosphate(ALP), 5’-nucleotidase, LDH isoenzyme. ③ Synthetic function: Prothrombin time, serum albumin. ④ Metabolic capacity: Galactose tolerance and antipyrine clearance ⑤ Detoxification : 5/23/2017 7
  • 8. Serum Bilirubin • Bilirubin is the catabolic product of haemoglobin produced within the reticuloendothelial system, released in unconjugated form which enters into the liver, converted to conjugated forms bilirubin mono and diglucuronides by the enzyme UDP- glucuronyltransferase.5/23/2017 8
  • 9. Normal serum bilirubin levels: • Total bilirubin: 4 to 19mol/L • Conjugated bilirubin (Direct ; glucuronide): 0 to 4 mol/L • Unconjugated bilirubin ( Indirect; bilirubin - albumin complex): up to 12 mol/L • The serum bilirubin levels more than 17μmol/L suggest liver diseases and levels above 24μmol/L indicate abnormal laboratory liver tests . Jaundice occurs when bilirubin becomes visible within the sclera, skin, and mucous membranes at a blood concentration of around 40 µmol/L . 5/23/2017 9
  • 10. • The occurrence of unconjugated hyperbilirubinemia due to over production of bilirubin, decreased hepatic uptake or conjugation or both. It is observed in genetic defect of UDP-glucuronyltransferase causing Gilbert's syndrome, Crigler-Najjar syndrome and reabsorption of large hematomas and ineffective erythropoiesis. • In viral hepatitis, hepatocellular damage, toxic or ischemic liver injury higher levels of serum conjugated bilirubin is seen. Hyperbilirubinemia in acute viral hepatitis is directly proportional to the degree of histological injury of hepatocytes and the longer course of the disease . 5/23/2017 10
  • 11. • It has been observed that the decrease of conjugated serum bilirubin is a bimodal fashion when the biliary obstruction is resolved. • Parenchymal liver diseases or incomplete extrahepatic obstruction due to biliary canaliculi give lower serum bilirubin value than those occur with malignant obstruction of common bile duct but the level remains normal in infiltrative diseases like tumours and granuloma. • Raised Serum bilirubin from 20.52 µmol/L to 143.64µmol/L in acute inflammation of appendix has been observed. 5/23/2017 11
  • 12. • In normal asymptomatic pregnant women total and free bilirubin concentrations were significantly lower during all three trimesters and a decreased conjugated bilirubin was observed in the second and third trimesters. The recent study has shown that a high serum total bilirubin level may protect neurologic damage due to stroke. 5/23/2017 12
  • 13. Alanine amino transferase (ALT) • ALT is found in kidney, heart, muscle and greater concentration in liver compared with other tissues of the body. ALT is purely cytoplasmic catalysing the transamination reaction. • Normal serum ALT is 7-56 U/ L • Any type of liver cell injury can reasonably increases ALT levels. • Elevated values up to 300 U/L are considered nonspecific. Marked elevations of ALT levels greater than 500 U/L observed most often in persons with diseases that affect primarily hepatocytes such as viral hepatitis, ischemic liver injury (shock liver) and toxin-induced liver damage. 5/23/2017 13
  • 14. • Despite the association between greatly elevated ALT levels and its specificity to hepatocellular diseases, the absolute peak of the ALT elevation does not correlate with the extent of liver cell damage . • Viral hepatitis like A, B, C, D and E may be responsible for a marked increase in aminotransferase levels. The increase in ALT associated with hepatitis C infection tends to be more than that associated with hepatitis A or B . • Moreover in patients with acute hepatitis C serum ALT is measured periodically for about 1 to 2 years. Persistence of elevated ALT for more than six months after an occurrence of acute hepatitis is used in the diagnosis of chronic hepatitis. 5/23/2017 14
  • 15. • Elevation in ALT levels are greater in persons with nonalcoholic steatohepatitis than in those with uncomplicated hepatic steatosis . In a recent study the hepatic fat accumulation in childhood obesity and nonalcoholic fatty liver disease causes serum ALT elevation. • Moreover increased ALT level was associated with reduced insulin sensitivity, adiponectin and glucose tolerance as well as increased free fatty acids and triglycerides. Presence of Bright liver and elevated plasma ALT level was independently associated with increased risk of the metabolic syndrome in adults. ALT level is normally elevated during 2nd trimester in asymptomatic normal pregnancy. 5/23/2017 15
  • 16. • In one of the study, serum ALT levels in symptomatic pregnant patients such as in hyperemesis gravidarum was 103.5U/L, in pre-eclampsia patients was 115U/L and in haemolysis with low platelet count patients showed 149U/L. However in the same study ALT rapidly drops more than 50% of the elevated values within 3 days indicating the improvement during postpartum. • One of the recent study has shown that coffee and caffeine consumption reduces the risk of elevated serum ALT activity in excessive alcohol consumption, viral hepatitis, iron overload, overweight, and impaired glucose metabolism. 5/23/2017 16
  • 17. Aspartate amino transferase (AST) • AST catalyse transamination reaction. AST exist two different isoenzyme forms which are genetically distinct, the mitochondrial and cytoplasmic form. • AST is found in highest concentration in heart compared with other tissues of the body such as liver, skeletal muscle and kidney. • Normal serum AST is 0 to 35U/L . • Elevated mitochondrial AST seen in extensive tissue necrosis during myocardial infarction and also in chronic liver diseases like liver tissue degeneration and necrosis . • About 80% of AST activity of the liver is contributed by the mitochondrial isoenzyme, whereas most of the circulating AST activity in normal people is derived from the cytosolic isoenzyme . 5/23/2017 17
  • 18. • However the ratio of mitochondrial AST to total AST activity has diagnostic importance in identifying the liver cell necrotic type condition and alcoholic hepatitis . • AST elevations often predominate in patients with cirrhosis and even in liver diseases that typically have an increased ALT . • AST levels in symptomatic pregnant patient in hyperemesis gravidarum were 73U/L, in pre-eclampsia 66U/L, and 81U/L was observed in hemolysis with low platelet count and elevated liver enzymes. 5/23/2017 18
  • 19. AST/ALT ratio • The ratio of AST to ALT has more clinical utility than assessing individual elevated levels. A coenzyme pyridoxal- 5'-phosphate deficiency may depress serum ALT activity and consequently increases the AST/ALT ratio • . The ratio increases in progressive liver functional impairment and found 81.3% sensitivity and 55.3% specificity in identifying cirrhotic patients . • Whereas mean ratio of 1.45 and 1.3 was found in alcoholic liver disease and post necrotic cirrhosis respectively. The ratio greater than 1.17 was found in one year survival among patients with cirrhosis of viral cause with 87% sensitivity and 52% specificity . 5/23/2017 19
  • 20. • An elevated ratio greater than 1 shows advanced liver fibrosis and chronic hepatitis C infection. However, an AST/ALT ratio greater than 2 characteristically is present in alcoholic hepatitis. • A recent study differentiated nonalcoholic steatohepatitis (NASH) from alcoholic liver disease showing AST/ALT ratio of 0.9 in NASH and 2.6 in patients with alcoholic liver disease. A mean ratio of 1.4 was found in patients with cirrhosis related to NASH. Wilson's disease can cause the ratio to exceed 4.5 and similar such altered ratio is found even in Hyperthyroidism. 5/23/2017 20
  • 21. Alkaline phosphatase (ALP) • ALP is present in mucosal epithelia of small intestine, proximal convoluted tubule of kidney, bone, liver and placenta. • It performs lipid transportation in the intestine and calcification in bone. The serum ALP activity is mainly from the liver with 50% contributed by bone . • Normal serum ALP is 41 to 133U/L . • In acute viral hepatitis, ALP usually remains normal or moderately increased. • Elevation of ALP with prolonged itching is related with Hepatitis A presenting cholestasis. Tumours secrete ALP into plasma and there are tumour specific isoenzymes such as Regan, Nagao and Kasahara . Hepatic and bony metastasis can also cause elevated levels of ALP.5/23/2017 21
  • 22. • Other diseases like infiltrative liver diseases, abscesses, granulomatous liver disease and amyloidosis may cause a rise in ALP. Mildly elevated levels of ALP may be seen in cirrhosis, hepatitis and congestive cardiac failure. • Low levels of ALP occur in hypothyroidism, pernicious anaemia, zinc deficiency and congenital hypophosphatasia. • ALP activity was significantly higher in the third trimester of asymptomatic normal pregnancy showing extra production from placental tissue. • ALP levels in hyperemesis gravidarum were 21.5U/L, in pre-eclampsia 14U/L, and 15U/L in haemolysis with low platelet count was seen during symptomatic pregnancy.5/23/2017 22
  • 23. • Transient hyperphosphataemia in infancy is a benign condition characterized by elevated ALP levels of several folds without evidence of liver or bone disease and it returns to normal level by 4 months. • ALP has been found elevated in peripheral arterial disease, independent of other traditional cardiovascular risk factors. Often clinicians are more confused in differentiating liver diseases and bony disorders when they see elevated ALP levels and in such situations measurement of gamma glutamyl transferase assists as it is raised only in cholestatic disorders and not in bone diseases. 5/23/2017 23
  • 24. Gamma Glutamyl Transferase (GGT) • GGT is a microsomal enzyme present in hepatocytes and biliary epithelial cells, renal tubules, pancreas and intestine. • It is also present in cell membrane performing transport of peptides into the cell across the cell membrane and involved in glutathione metabolism. • Serum GGT activity mainly attributed to hepatobiliary system even though it is found in more concentration in renal tissue . • The normal level of GGT is 9 to 85 U/L . • In acute viral hepatitis the levels of GGT will reach the peak in the second or third week of illness and in some patients remain elevated for 6 weeks .5/23/2017 24
  • 25. • Increased level is seen in about 30% of patients with chronic hepatitis C infection . Other conditions like uncomplicated diabetes mellitus, acute pancreatitis, myocardial infarction, anorexia nervosa, Gullian barre syndrome, hyperthyroidism, obesity and dystrophica myotonica caused elevated levels of GGT . • Elevated serum GGT levels of more than 10 times is observed in alcoholism. It is partly related to structural liver damage, hepatic microsomal enzyme induction or alcoholic pancreatic damage . • GGT can also be an early marker of oxidative stress since serum antioxidant carotenoids namely lycopene, α-carotene, β- carotene, and β-cryptoxanthin are inversely associated with alcohol-induced increase of serum GGT found in moderate and heavy drinkers .5/23/2017 25
  • 26. • GGT levels may be 2–3 times greater than the upper reference value in more than 50% of the patients with nonalcoholic fatty liver disease. • There is a significant positive correlation between serum GGT and triglyceride levels in diabetes and the level decreases with treatment especially when treated with insulin. • Whereas serum GGT does not correlate with hepatomegaly in diabetes mellitus. Serum GGT activity was significantly lower in the second and third trimesters of normal asymptomatic pregnancy. 5/23/2017 26
  • 27. • The levels of GGT in hyperemesis gravidarum was 45U/L, in pre- eclampsia 17U/L, and 35U/L in hemolysis with low platelet count and elevated liver enzymes was found during symptomatic pregnancy [4]. The primary usefulness of GGT is limited in ruling out bone disease as GGT is not found in bone. 5/23/2017 27
  • 28. 5’ Nucleotidase (NTP) • NTP is a glycoprotein generally disseminated throughout the tissues of the body localised in cytoplasmic membrane catalyzing release of inorganic phosphate from nucleoside-5- phosphates. • The normal range established is 0 to 15U/L . • Raised levels of NTP activity were found in patients with obstructive jaundice, parenchymal liver disease, hepatic metastases and bone disease . • NTP is precise marker of early hepatic primary or secondary tumours. ALP levels also increased in conjugation with NTP showing intra or extra hepatic obstruction due to malignancy. • Elevation of NTP is found in acute infective hepatitis and also in chronic hepatitis.5/23/2017 28
  • 29. • In acute hepatitis elevation of NTP activity is more when compared with chronic hepatitis and it is attributed to shedding of plasma membrane with ecto NTP activity due to cell damage, or leakage of bile containing high NTP activity . Serum NTP activity was slightly but significantly higher in the second and third trimesters of pregnancy . 5/23/2017 29
  • 30. Ceruloplasmin • Ceruloplasmin is synthesized in the liver and is an acute phase protein. It binds with the copper and serves as a major carrier for copper in the blood . • Normal plasma level of ceruloplasmin is 200 to 600mg/L . • The level is elevated in infections, rheumatoid arthritis, pregnancy, non Wilson liver disease and obstructive jaundice. Low levels may also be seen in neonates, menke’s disease, kwashiorkor, marasmus, protein losing enteropathy, copper deficiency and aceruloplasminemia . • In Wilson's disease ceruloplasmin level is depressed. Decreased rate of synthesis of the ceruloplasmin is responsible for copper accumulation in liver because of copper transport defect in golgi apparatus, since ATP7B is affected . • Serum ceruloplasmin levels were elevated in the chronic active liver disease (CALD) but lowered in the Wilson’s disease (WD). Hence it is the most reliable routine chemical screening test to differentiate between CALD and WD. 5/23/2017 30
  • 31. α-fetoprotein (AFP) • AFP is the major serum protein in the developing mammalian foetus produced at high levels by the foetal liver and visceral endoderm of the yolk sac and at low levels by foetal gut and kidney. • AFP is required for female fertility during embryonic development by protecting the developing female brain from prenatal exposure to estrogen . In response to liver injury and during the early stages of chemical hepatocarcinogenesis led to the conclusion that maturation arrest of liver-determined tissue stem cells give rise to hepatocellular carcinomas. 5/23/2017 31
  • 32. • The normal level of AFP is 0 to 15µg/L • . An AFP value above 400 - 500µg/L has been considered to be diagnostic for hepatocellular carcinoma (HCC) in patients with cirrhosis. • A high AFP concentration ≥ 400µg/L in HCC patients is associated with greater tumour size, bilobar involvement, portal vein invasion and a lower median survival rate . • Higher serum AFP levels independently predict a lower sustained virological response (SVR) rate among patients with chronic hepatitis C . 5/23/2017 32
  • 33. • There are three different AFP variants, differing in their sugar chains (AFP-L1, AFP-L2, AFP-L3). AFP-L agglutinin (LCA) -bound fraction, is the main glycoform of AFP in the serum of patients with non- malignant chronic liver disease. In contrast, Lens culinaris-reactive AFP, also known as AFP-L3, is the main glycoform of AFP in the serum of HCC patients and it can be detected in approximately one third of patients with small HCC (< 3 cm), when cut-off values of 10% to 15% are used. AFP-L3 acts as a marker for clearance of HCC after treatment. It is reported that an AFP-L3 level of 15% or more is correlated with HCC- associated portal vein invasion. 5/23/2017 33
  • 34. • Estimating the AFP-L3 / AFP ratio is helpful in diagnosis and prognosis of HCC. • There is a direct association between second- trimester maternal serum alpha-fetoprotein levels and the risk of sudden infant death syndrome (SIDS), which may be mediated in part through impaired foetal growth and preterm birth. 5/23/2017 34
  • 35. Prothrombin time and INR • The prothrombin time (also called the “protime” or PT) and the INR are tests used to assess blood clotting. Blood clotting factors are proteins made by the liver. When the liver is significantly injured, these proteins are not produced normally. The PT and INR are also useful liver function tests since there is a good correlation between abnormalities in coagulation measured by these tests and the degree of liver dysfunction. The values for the PT are usually expressed in seconds and compared to a control patient’s blood (normal +/- 2 seconds of control). 5/23/2017 35
  • 36. Albumin • Albumin is a major protein which is formed by the liver. Although there are many factors which can affect the level of albumin circulating in the blood, chronic liver disease causes a decrease in the amount of albumin produced, and therefore the level of albumin in the blood is reduced. Albumin is also part of most automated chemistry screening panels (normal > 35 g/L). 5/23/2017 36
  • 37. Other Liver Tests • Highly specialized tests may be used to indicate more specifically the presence of certain liver diseases. For example:Specific antibodies, proteins, and nucleic acids may be used to indicate the presence of viral hepatitis B (HBsAg, HBV DNA) or C (eg. anti-HCV antibodies, HCV RNA). • Elevations in the serum iron, transferrin saturation and ferritin may indicate the presence of hemochromatosis. • A deficiency of ceruloplasmin is usually seen in patients with a copper metabolism disorder called Wilson disease. 5/23/2017 37
  • 38. • A low level of alpha-1-antitrypsin may indicate the presence of lung and/or liver disease in children and adults due to alpha-1-antitrypsin deficiency. • Immunologic tests such as the antimitochondrial antibody may suggest the presence of primary biliary cholangitis (PBC). Antinuclear and/or anti-smooth muscle antibodies may indicate the presence of autoimmune hepatitis. 5/23/2017 38
  • 40. Conclusion • Laboratory liver tests help to elucidate the alteration of markers which reflect the liver disease. The assessment of enzyme abnormalities like, the predominant pattern of enzyme alteration, the magnitude of enzyme alteration in the case of aminotransferases, isolated elevation or in conjugation with some other parameter, the rate of change and the nature of the course of alteration or follow up of 6 months to 1-2 years helps in the diagnosis of the disease. • But a single laboratory liver test is of little value in screening for liver disease as many serious liver diseases may be associated with normal levels and abnormal levels might be found in asymptomatic healthy individuals. The pattern of enzyme abnormality, interpreted in the context of the patient’s symptoms can aid in directing the subsequent diagnosis.5/23/2017 40
  • 41. REFERENCES 1.Thapa BR, Anuj W. Liver Function Tests and their Interpretation. Indian J Pediatr 2007; 74: 663- 671. 2.Wong HY, Tan JYL, Lim CC. Abnormal liver function test in symptomatic pregnant patient: The local experience in Singapore. Annals academy of Medicine 2004; 33: 204-208. 3. Beckingham IJ, Ryder SD. Clinical review ABC of diseases of liver, pancreas, and biliary system Investigation of liver and biliary disease. BMJ 2001; 322: 33-36. 4. AGA Technical Review on the Evaluation of Liver Chemistry Tests. Gastroenterology 2002; 123: 1367–1384. 5/23/2017 41
  • 42. 5.Sayal SK, Gupta CM, Das AL, et al. A comparative study of liver function tests in patients of chronic liver disorders with and without cutaneous manifestations. Ind J Dermatol Venereol Leprol 1997; 63: 15-19. 5/23/2017 42